Skip to ContentSkip to Navigation
How to find us B. (Bert) van der Vegt

Publications

Mesothelin/CD3 half-life extended bispecific T-cell engager molecule shows specific tumor uptake and distributes to mesothelin and CD3 expressing tissues

Prediction of Incident Cancers in the Lifelines Population-Based Cohort

Abacept treatment for patients with early active primary Sjögren's syndrome: OPEN-LABEL EXTENSION PHASE OF A RANDOMIZED CONTROLLED PHASE III TRIAL

Abatacept treatment for patients with early active primary Sjogren's syndrome: a single-centre, randomised, double-blind, placebo-controlled, phase 3 trial (ASAP-III study)

Analytical validation and prognostic potential of an automated digital scoring protocol for Ki67: An International Ki67 Working Group study

Bcl6 for identification of germinal centres in salivary gland biopsies in primary Sjogren's syndrome

Biological tumor markers associated with local control after primary radiotherapy in laryngeal cancer: A systematic review

Comparison of Carboplatin With 5-Fluorouracil vs. Cisplatin as Concomitant Chemoradiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma

Cyclin E expression is associated with high levels of replication stress in triple-negative breast cancer

Distinct Biomarker Profiles and Clinical Characteristics in T1-T2 Glottic and Supraglottic Carcinomas

Read more

Press/media

Kankercellen onder de loep

Zien welke kanker het is